
Paranagama D, Colucci P, Evans KA, Bonafede M, Parasuraman S. Are patients with high-risk polycythemia vera receiving cytoreductive medications? a retrospective analysis of real-world data. Exp Hematol Oncol. 2018, 7:16. doi: 10.1186/s40164-018-0107-8.
Advertisement
Articles by Paranagama D, Colucci P, Evans KA, Bonafede M, Parasuraman S. Are patients with high-risk polycythemia vera receiving cytoreductive medications? a retrospective analysis of real-world data. Exp Hematol Oncol. 2018, 7:16. doi: 10.1186/s40164-018-0107-8.

Advertisement
Latest Updated Articles
Study Summary: Real-World Adherence to Cytoreductive Treatment in Polycythemia Vera Is LowPublished: August 28th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
3
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5



